Fangying Xu

1.7k total citations
35 papers, 1.3k citations indexed

About

Fangying Xu is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fangying Xu has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fangying Xu's work include Cancer Cells and Metastasis (6 papers), Genetic factors in colorectal cancer (6 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Fangying Xu is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Genetic factors in colorectal cancer (6 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Fangying Xu collaborates with scholars based in China, Hong Kong and Taiwan. Fangying Xu's co-authors include Maode Lai, Maode Lai, Qiong Huang, Si Li, Maode Lai, Xiaobo Li, Yimin Zhu, Sihua Peng, Xuesong Wu and Xiaobin Ren and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and Journal of Agricultural and Food Chemistry.

In The Last Decade

Fangying Xu

34 papers receiving 1.2k citations

Peers

Fangying Xu

ONCOL

GENET

IMMUN

Zhanguo Zhang China

Cheng Fang China

Jiaxiang Wang China

Dalila Lucíola Zanette Brazil

J. G. Leroy Belgium

Michael T. Story United States

Yusuke Kito Japan

Kyoko Yamada Japan

Wouter F.J. Feitz Netherlands

Bin Qiao China

Zhanguo Zhang China

Fangying Xu

773 ×1.4

426 ×1.1

ONCOL

455 ×1.7

129 ×0.6

GENET

132 ×0.8

IMMUN

Citations per year, relative to Fangying Xu Fangying Xu (= 1×) peers Zhanguo Zhang

Countries citing papers authored by Fangying Xu

Since Specialization

Citations

This map shows the geographic impact of Fangying Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangying Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangying Xu more than expected).

Fields of papers citing papers by Fangying Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangying Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangying Xu. The network helps show where Fangying Xu may publish in the future.

Co-authorship network of co-authors of Fangying Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangying Xu. A scholar is included among the top collaborators of Fangying Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangying Xu. Fangying Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Fangying, Nian Liu, Y. Gao, et al.. (2025). Therapeutic Potential of Raspberry Extract in High-Fat Diet-Induced Liver Injury via Apoptosis and AMPK/PPARα Pathways. Journal of Agricultural and Food Chemistry. 73(15). 9408–9423. 1 indexed citations

Chen, Lin, Yuwei Jiang, Jiannan Qiu, et al.. (2025). Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a. International Immunopharmacology. 157. 114768–114768. 1 indexed citations

Qiu, Jiannan, Fangying Xu, Yanyan Gao, et al.. (2025). Metabolic restoration: Rhubarb polysaccharides as a shield against non-alcoholic fatty liver disease. International Journal of Biological Macromolecules. 305(Pt 2). 141151–141151. 4 indexed citations

Qiu, Jiannan, Lin Chen, Guilin Ren, et al.. (2024). Geniposide dosage and administration time: Balancing therapeutic benefits and adverse reactions in liver disease treatment. Phytomedicine. 132. 155799–155799. 6 indexed citations

Sun, Liang, Jiahui Wang, Yuxuan Li, et al.. (2024). Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer. BMC Cancer. 24(1). 567–567. 6 indexed citations

Qiu, Jiannan, Lin Chen, Ling Zhang, et al.. (2023). Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy. Phytomedicine. 121. 155111–155111. 41 indexed citations

Sun, Liang, et al.. (2023). NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances. Pharmaceuticals. 16(6). 783–783. 23 indexed citations

Xu, Fangying, et al.. (2022). Small Size and High Isolation MIMO Antenna System for 5G Mobile Terminals. 162–166.

Li, Si, Jun Zhang, Xuesong Wu, et al.. (2021). S100A8 promotes epithelial‐mesenchymal transition and metastasis under TGF‐β/USF2 axis in colorectal cancer. Cancer Communications. 41(2). 154–170. 70 indexed citations

10.

Wu, Xuesong, Jun Zhang, Lichao Sun, et al.. (2021). Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer. SHILAP Revista de lepidopterología. 9(1). 23–23. 40 indexed citations

11.

Xu, Fangying, Si Li, Jing Zhang, et al.. (2018). Cancer Stemness, Immune Cells, and Epithelial–Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma. Clinical Colorectal Cancer. 17(3). e579–e592. 24 indexed citations

12.

Li, Hui, Si Li, Xianwen Meng, et al.. (2017). The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis. Scientific Reports. 7(1). 4915–4915. 48 indexed citations

13.

Chen, Wuzhen, Wubin Wang, Xuesong Wu, et al.. (2016). Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition. Molecular Cancer. 15(1). 77–77. 72 indexed citations

14.

Zhu, Shuzhen, Fangying Xu, Enbo Xu, et al.. (2015). IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer. Cell Death and Disease. 6(3). e1695–e1695. 27 indexed citations

15.

Zhu, Shuzhen, Fangying Xu, Jing Zhang, Wenjing Ruan, & Maode Lai. (2014). Insulin-like growth factor binding protein-related protein 1 and cancer. Clinica Chimica Acta. 431. 23–32. 20 indexed citations

16.

Peng, Sihua, Yimin Zhu, Bingjian Lü, et al.. (2012). TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121 174 subjects. Mutagenesis. 28(1). 25–37. 63 indexed citations

17.

Peng, Sihua, Yimin Zhu, Fangying Xu, et al.. (2011). FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Medicine. 9(1). 71–71. 150 indexed citations

18.

Ruan, Wenjing, Shuzhen Zhu, Haibing Wang, et al.. (2010). IGFBP-rP1, a potential molecule associated with colon cancer differentiation. Molecular Cancer. 9(1). 281–281. 15 indexed citations

19.

Xu, Fangying, et al.. (2009). Micropapillary Component in Colorectal Carcinoma is Associated With Lymph Node Metastasis in T1 and T2 Stages and Decreased Survival Time in TNM Stages I and II. The American Journal of Surgical Pathology. 33(9). 1287–1292. 56 indexed citations

20.

Ruan, Wenjing, Enping Xu, Fangying Xu, et al.. (2007). IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis. Cancer Biology & Therapy. 6(3). 354–359. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact